conversion
-
Biologics
InVivo Therapeutics Announces Sixth Patient Conversion in The INSPIRE Study of the Neuro-Spinal Scaffold™
CAMBRIDGE, Mass.–(BUSINESS WIRE)– InVivo Therapeutics Holdings Corp. (NVIV) today announced that the patient enrolled in December in the INSPIRE study of…
Read More » -
Financial
Cesca Therapeutics Announces Conversion of $12.5 Million in Senior Secured Debt to Equity
RANCHO CORDOVA, Calif., Aug. 24, 2016 (GLOBE NEWSWIRE) — Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today…
Read More »